CN100405060C - 一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法 - Google Patents
一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法 Download PDFInfo
- Publication number
- CN100405060C CN100405060C CNB2006100018354A CN200610001835A CN100405060C CN 100405060 C CN100405060 C CN 100405060C CN B2006100018354 A CNB2006100018354 A CN B2006100018354A CN 200610001835 A CN200610001835 A CN 200610001835A CN 100405060 C CN100405060 C CN 100405060C
- Authority
- CN
- China
- Prior art keywords
- relative
- peak area
- retention time
- peaks
- leech
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000545744 Hirudinea Species 0.000 title claims abstract description 97
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000001228 spectrum Methods 0.000 title abstract description 7
- 241000237902 Hirudo medicinalis Species 0.000 title 1
- 239000000463 material Substances 0.000 claims abstract description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 27
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims abstract description 20
- 239000012088 reference solution Substances 0.000 claims abstract description 15
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 13
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 13
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000012071 phase Substances 0.000 claims abstract description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000007791 liquid phase Substances 0.000 claims abstract description 7
- 238000001514 detection method Methods 0.000 claims abstract description 6
- 239000002504 physiological saline solution Substances 0.000 claims abstract description 6
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 5
- 239000000945 filler Substances 0.000 claims abstract description 4
- 239000002904 solvent Substances 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 230000014759 maintenance of location Effects 0.000 claims description 80
- 238000002360 preparation method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000003480 eluent Substances 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 5
- 239000013558 reference substance Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 238000004811 liquid chromatography Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 9
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 8
- 238000004587 chromatography analysis Methods 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 2
- 238000010828 elution Methods 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 12
- 239000000284 extract Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000012850 discrimination method Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 241000237678 Hirudinidae Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 241000964941 Whitmania Species 0.000 description 2
- 241000258623 Whitmania pigra Species 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- JWHHANVGNNWIRI-UHFFFAOYSA-N methanol phosphoric acid hydrate Chemical group O.OC.OP(O)(O)=O JWHHANVGNNWIRI-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
T(min) | A(%) | B(%) |
0 | 100 | 0 |
5 | 100 | 0 |
10 | 99 | 1 |
50 | 0 | 100 |
T(min) | A(%) | B(%) |
0 | 100 | 0 |
5 | 100 | 0 |
10 | 99 | 1 |
50 | 0 | 100 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100018354A CN100405060C (zh) | 2006-01-24 | 2006-01-24 | 一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100018354A CN100405060C (zh) | 2006-01-24 | 2006-01-24 | 一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1844911A CN1844911A (zh) | 2006-10-11 |
CN100405060C true CN100405060C (zh) | 2008-07-23 |
Family
ID=37063855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100018354A Active CN100405060C (zh) | 2006-01-24 | 2006-01-24 | 一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100405060C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102914612B (zh) * | 2011-08-06 | 2015-10-21 | 河北以岭医药研究院有限公司 | 一种菲牛蛭药材指纹图谱的测定方法 |
CN103558329B (zh) * | 2013-11-25 | 2015-05-13 | 鲁南厚普制药有限公司 | 水蛭指纹图谱的建立方法及其标准指纹图谱 |
CN103898235B (zh) * | 2014-04-21 | 2017-03-15 | 牡丹江友搏药业有限责任公司 | 一种水蛭的dna条形码分子鉴定方法 |
CN113984936A (zh) * | 2021-12-09 | 2022-01-28 | 车延柠 | 一种水蛭酶解多肽的lc-ms特征图谱、检测方法及其应用 |
CN115902077B (zh) * | 2022-10-17 | 2024-06-11 | 广东一方制药有限公司 | 蚂蟥的特征图谱及其构建方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1034335C (zh) * | 1988-06-16 | 1997-03-26 | 默里尔多药物公司 | 由南美水蛭中提取和纯化抗凝血成分 |
EP1132406A1 (en) * | 1998-11-25 | 2001-09-12 | Universitat Autonoma De Barcelona | Inhibitor of metalocarboxypeptidases as fibrinolytic agent |
CN1071337C (zh) * | 1994-09-07 | 2001-09-19 | 东国制药株式会社 | 用亲合色谱法提纯水蛭素的方法 |
-
2006
- 2006-01-24 CN CNB2006100018354A patent/CN100405060C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1034335C (zh) * | 1988-06-16 | 1997-03-26 | 默里尔多药物公司 | 由南美水蛭中提取和纯化抗凝血成分 |
CN1071337C (zh) * | 1994-09-07 | 2001-09-19 | 东国制药株式会社 | 用亲合色谱法提纯水蛭素的方法 |
EP1132406A1 (en) * | 1998-11-25 | 2001-09-12 | Universitat Autonoma De Barcelona | Inhibitor of metalocarboxypeptidases as fibrinolytic agent |
Non-Patent Citations (4)
Title |
---|
5种水蛭中尿嘧啶、黄嘌呤、次黄嘌呤的含量比较. 刘丽芳等.中药材,第22卷第1期. 1999 |
5种水蛭中尿嘧啶、黄嘌呤、次黄嘌呤的含量比较. 刘丽芳等.中药材,第22卷第1期. 1999 * |
高效液相色谱法对不同产地水蛭的鉴别分析. 姜艳等.时珍国医国药,第15卷第8期. 2004 |
高效液相色谱法对不同产地水蛭的鉴别分析. 姜艳等.时珍国医国药,第15卷第8期. 2004 * |
Also Published As
Publication number | Publication date |
---|---|
CN1844911A (zh) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104215698B (zh) | 裸花紫珠药材、中间体及其制剂的指纹图谱检测方法和标准指纹图谱 | |
CN102119961B (zh) | 一种复方丹参滴丸的检测方法 | |
CN109828059A (zh) | 桂枝芍药知母汤的检测方法 | |
CN100405060C (zh) | 一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法 | |
CN106053700B (zh) | 一种首乌益智胶囊的指纹图谱测定方法 | |
CN100376894C (zh) | 一种地龙指纹图谱的建立方法和地龙药材的鉴别方法 | |
CN101028460B (zh) | 一种中药制剂金嗓清音丸的质量检测方法 | |
CN114384184B (zh) | 一种一测多评测定川芎中有效成分的方法 | |
CN102879516B (zh) | 补阳还五汤的鉴别和含量测定方法 | |
CN112730674B (zh) | 一种罗汉茶的质量检测方法 | |
CN114487242A (zh) | 鸡内金和/或醋鸡内金及制剂的特征图谱及其构建方法和含量测定方法 | |
CN102068549A (zh) | 中药制剂清热凉血丸的质量控制方法 | |
CN105004833A (zh) | 一种治疗急性痛风性关节炎、痛风的中药制剂的检测方法 | |
CN109709222B (zh) | 一种感冒灵和复方感冒灵的成分检测方法 | |
CN1982892A (zh) | 建立疏血通注射液或其中间体指纹图谱的方法及其应用 | |
CN1939472B (zh) | 一种治疗糖尿病的复方制剂的检测方法 | |
CN114216980B (zh) | 一种银柴胡hplc-elsd指纹图谱建立方法 | |
CN109917044A (zh) | 桂枝芍药知母汤的检测方法 | |
CN102854282B (zh) | 一种治疗喉症的中药复方制剂的检测方法 | |
CN101339171B (zh) | 一种红花黄色素指纹图谱及其建立方法 | |
CN100515445C (zh) | 治疗广泛性焦虑症的中药制剂的质量检测方法 | |
CN116008418B (zh) | 雪白睡莲花药材的hplc指纹图谱及判定含量模型的构建方法及雪白睡莲花的鉴别方法 | |
CN101625348B (zh) | 驴胶补血制剂及其原料、中间体的指纹图谱测定方法 | |
CN101387620B (zh) | 乌灵胶囊标准指纹图谱的建立方法和乌灵胶囊的鉴别方法 | |
CN112180022B (zh) | 一种炒蒺藜或蒺藜中蒺藜皂苷k含量的测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: MUDANJIANG YOUBO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI ZHENGUO Effective date: 20110707 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110707 Address after: 157011, 6, culture street, Aimin District, Heilongjiang, Mudanjiang Patentee after: Mudanjiang Youbo Pharmaceutical Co.,Ltd. Address before: 157011, 6, culture street, Aimin District, Heilongjiang, Mudanjiang Patentee before: Li Zhenguo |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 157011, 6, culture street, Aimin District, Heilongjiang, Mudanjiang Patentee after: Mudanjiang Youbo Pharmaceutical Co., Ltd. Address before: 157011, 6, culture street, Aimin District, Heilongjiang, Mudanjiang Patentee before: Mudanjiang Youbo Pharmaceutical Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 157013 Heilongjiang province Mudanjiang City Yangming District Yumin Road No. 288 Patentee after: Mudanjiang Youbo Pharmaceutical Co., Ltd. Address before: 157011, 6, culture street, Aimin District, Heilongjiang, Mudanjiang Patentee before: Mudanjiang Youbo Pharmaceutical Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 157013 Heilongjiang province Mudanjiang City Yangming District Yumin Road No. 288 Patentee after: Mudanjiang Youbo Pharmaceutical Co.,Ltd. Address before: 157013 Heilongjiang province Mudanjiang City Yangming District Yumin Road No. 288 Patentee before: Mudanjiang Youbo Pharmaceutical Co., Ltd. |